Summit Therapeutics Inc. announced that Ankur Dhingra has been appointed as Chief Financial Officer, effective June 1, 2022. “We are in a pivotal time for Team Summit as we seek to expand our portfolio of pipeline assets through potential collaborations and possible acquisitions,” said Robert W. Duggan, Chairman and Chief Executive Officer of Summit. “Ankur’s leadership…